NASDAQ

This Biotech Just Neared A 17-Year High On Strong Cancer Regimen

//
Categories
Nektar Therapeutics ( NKTR ) launched to a nearly 17-year high Monday on strong combination data for its immuno-oncology drug combined with Bristol-Myers Squibb ‘s ( BMY ) Opdivo in skin, kidney and lung cancers. [ibd-display-video id=2633855 width=50 float=left autostart=true]By the closing bell on the stock market today , Nektar soared by more than 14%...
Read More →

Why Are Bank Stocks in Retreat?

//
Categories
If you’re an investor in bank stocks, you’d be excused for wondering why they’ve been in retreat, with the KBW Bank Index closing down the past five days in a row. What’s behind the decline? It’s impossible to say for sure, but you’d be excused for thinking that the growing sense of uncertainty coursing through...
Read More →

Adidas' U.S. Boss Talks Amazon, Retail Strategies, And Kanye's Real Impact

//
Categories
Now that the haze of nostalgia is starting to settle, it’s becoming clearer that Adidas ‘ ( ADDYY ) American resurgence isn’t just a one-off fad built on the back of fashion geeks, but perhaps a more permanent comeback to the spotlight. [ibd-display-video id=2553787 width=50 float=left autostart=true]Adidas’ currency-neutral revenue rose 12% to 5.677 billion euros, missing...
Read More →

Why Applied Optoelectronics, MBIA, and Forterra Jumped Today

//
Categories
Wednesday was another calm day for the stock market, although major benchmarks generally posted modest gains from where they began the day. Investors reflected on the rise in the financial markets since the presidential election one year ago, and despite numerous concerns and uncertainties on the geopolitical and macroeconomic fronts both in the U.S. and...
Read More →

Why Invacare Corporation Is Rising Today

//
Categories
What happened In response to the company’s report of third-quarter results, shares of Invacare Corporation (NYSE: IVC) , a manufacturer and distributor of medical equipment , rose 19% as of 3:10 p.m. EST on Wednesday. So what Here’s a review of the headline numbers from the company’s third quarter: Revenue decreased 6% to $251 million....
Read More →

Gartner Inc. Delivers 44% Revenue Growth

//
Categories
Gartner ‘s (NYSE: IT)  third-quarter results gave evidence that its growth-through-acquisition strategy is creating value for clients and shareholders alike. Gartner results: The raw numbers Metric Q3 2017 Q3 2016 Year-Over-Year Change Revenue $828.085 million $574.059 million 44% Adjusted net income $59.516 million $48.225 million 23% Adjusted EPS $0.65 $0.58 12% Data source: Gartner Q3 2017...
Read More →
1 2 3 173